Tobacco Company Philip Morris Under Fire For ‘Ironic’ Decision to Invest in Lung Health Products

Philip Morris International, an American-Swiss multinational cigarette and tobacco manufacturing company, has been making headlines, some wanted and some unwanted, with their announcement to acquire two overseas companies specializing in oral and inhaled products.

The leading cigarette manufacturer in the U.S. for more than 40 years has agreed to acquire Fertin Pharma A/S for about $820 million and the UK-based Vectura Group PLC for $1.2 billion.

The Vectura deal came under immediate fire in medical circles. Vectura makes respiratory drug inhalers that can even help with smoker’s lungs while Philip Morris International still makes most of its money from brands like Marlboro and Chesterfield.

The Evening Standard quoted Cancer Research UK chief executive Michelle Mitchell saying, “It’s ironic that a tobacco company wants
Read more…

Please follow and like us: